You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 21, 2025

Details for Patent: 9,855,211


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,855,211 protect, and when does it expire?

Patent 9,855,211 protects ZELSUVMI and is included in one NDA.

This patent has fifteen patent family members in seven countries.

Summary for Patent: 9,855,211
Title:Topical compositions and methods of using the same
Abstract:The present invention relates generally to topical compositions and methods of using the same.
Inventor(s):Doxey Ryan, Sabouni Adam, Kougoulos Eleftherios, Stasko Nathan
Assignee:Novan, Inc.
Application Number:US14191958
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,855,211

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This analysis will delve into the specifics of United States Patent 9,855,211, exploring its claims, scope, and the broader patent landscape.

Patent Overview

United States Patent 9,855,211, hereafter referred to as the '211 patent, is a document that grants exclusive rights to the inventor for a specific invention. To analyze this patent, we need to consider several key aspects:

Invention Description

The '211 patent describes an invention that typically falls within a specific technological or scientific domain. For instance, if it pertains to a medical device, the description would include details about the device's components, its functionality, and how it differs from existing technologies[4].

Claims

Independent Claims

The independent claims in a patent are the broadest claims that define the invention. These claims are crucial because they set the boundaries of what is protected by the patent. For the '211 patent, independent claims would outline the core elements of the invention that distinguish it from prior art[3].

Dependent Claims

Dependent claims are narrower and build upon the independent claims. They specify additional features or limitations that further define the invention. These claims help to provide a clearer picture of the invention's scope and can be used to defend against potential infringement[3].

Scope of the Patent

Claim Language

The scope of a patent is often determined by the language used in the claims. Metrics such as independent claim length and independent claim count can provide insights into the breadth of the patent. Longer independent claims and a higher number of claims can indicate a broader scope, but may also raise questions about the patent's clarity and validity[3].

Prior Art

The scope of the '211 patent is also influenced by prior art, which includes all existing knowledge and inventions in the same field. Patent examiners evaluate the claimed invention against prior art to determine its novelty and non-obviousness. Any overlap with prior art can limit the scope of the patent[1].

Patent Landscape

Related Patents

Understanding the patent landscape involves identifying related patents that may overlap or complement the '211 patent. This includes analyzing patents cited in the '211 patent, as well as other patents in the same technological area. Tools like PubWEST, available at the USPTO and depository libraries, can facilitate this search by providing access to multiple databases of full-text U.S. patents and international patent documents[4].

Industry Trends

The patent landscape is also shaped by industry trends and the activities of other inventors and companies. For example, if the '211 patent is in a highly competitive field like pharmaceuticals, it would be important to track the patent expirations and new filings of competitors, such as those related to drug patents like Zelsuvmi[5].

Legal and Regulatory Framework

USPTO Guidelines

The United States Patent and Trademark Office (USPTO) provides guidelines and regulations that govern the patent process. The '211 patent must comply with these guidelines, including the requirements for novelty, non-obviousness, and utility. The USPTO's mission to "promote the progress of science and useful arts" by securing exclusive rights for inventors is central to this framework[1].

Statutory Mandates

Statutes such as the American Inventors Protection Act (AIPA) and the Leahy-Smith America Invents Act (AIA) have significant impacts on patent rights. These laws aim to improve patent quality, reduce application backlogs, and provide alternatives to costly litigation, all of which can affect the scope and claims of the '211 patent[1].

Economic and Cultural Impact

Job Creation and Economic Growth

Patents like the '211 patent play a crucial role in promoting economic growth and job creation. By securing exclusive rights for inventors, patents incentivize innovation and investment in research and development. This aligns with the USPTO's mission to support economic and cultural growth through the protection of intellectual property[1].

Historical Significance

The issuance of patents is not just a legal process but also a historical milestone. For example, the issuance of U.S. patent number 10 million was a significant event that highlighted the ongoing importance of patents in driving innovation and progress[1].

Challenges and Controversies

Patent Quality Debates

There are ongoing debates about patent quality, with some arguing that patents have become overly broad and less clear. This can lead to increased licensing and litigation costs, which may diminish the incentives for innovation. Metrics like independent claim length and count can help in assessing these concerns[3].

Litigation and Licensing

The '211 patent, like any other patent, is subject to potential litigation and licensing agreements. The clarity and validity of the patent claims are critical in these contexts, as they can significantly impact the outcome of legal disputes and the terms of licensing agreements.

Tools and Resources

PubWEST and USPTO Databases

Tools like PubWEST and the USPTO's full-text and image database are essential for searching and analyzing patents. These resources allow for comprehensive searches across multiple databases, facilitating a thorough understanding of the patent landscape[4].

Legal and Educational Resources

The New York State Library and other depository libraries offer extensive collections of patent-related resources, including guides and journals on intellectual property law. These resources can provide valuable insights and support for inventors and legal professionals[4].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of the patent.
  • Prior Art: Evaluating the invention against prior art is essential for ensuring novelty and non-obviousness.
  • Patent Landscape: Analyzing related patents and industry trends helps in understanding the broader context.
  • Legal Framework: Compliance with USPTO guidelines and statutory mandates is vital.
  • Economic Impact: Patents play a significant role in economic growth and job creation.
  • Challenges: Debates over patent quality and potential litigation highlight the need for clear and valid claims.

Frequently Asked Questions

Q: What is the significance of independent claims in a patent?

A: Independent claims define the broadest scope of the invention and set the boundaries of what is protected by the patent.

Q: How does prior art affect the scope of a patent?

A: Prior art limits the scope of a patent by ensuring that the claimed invention is novel and non-obvious compared to existing knowledge and inventions.

Q: What tools are available for searching and analyzing patents?

A: Tools like PubWEST and the USPTO's full-text and image database are available for comprehensive searches across multiple patent databases.

Q: Why is patent quality a subject of debate?

A: Debates over patent quality focus on issues such as overly broad claims, decreased clarity, and questionable validity, which can increase licensing and litigation costs.

Q: How do patents contribute to economic growth?

A: Patents incentivize innovation and investment in research and development, leading to job creation and economic growth.

Cited Sources

  1. USPTO Performance and Accountability Report 2018 - United States Patent and Trademark Office.
  2. US Patent Document - US 11,541,105 B2.
  3. Patent Claims and Patent Scope - Hoover Institution.
  4. Selected Highlights of the NYSL US Patent Collection - New York State Library.
  5. Zelsuvmi patent expiration - Pharsight.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 9,855,211

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Lnhc ZELSUVMI berdazimer sodium GEL;TOPICAL 217424-001 Jan 5, 2024 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y METHOD OF APPLYING RELEASED NITRIC OXIDE TO SKIN FROM COMBINATION INCLUDING ANHYDROUS ALCOHOL GEL ⤷  Try for Free
Lnhc ZELSUVMI berdazimer sodium GEL;TOPICAL 217424-001 Jan 5, 2024 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y METHOD OF INCREASING RELEASE OF NITRIC OXIDE FROM ANHYDROUS ALCOHOL GEL ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 2 of 2 entries

International Family Members for US Patent 9,855,211

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2014223164 ⤷  Try for Free
Brazil 112015019657 ⤷  Try for Free
Canada 2900557 ⤷  Try for Free
Canada 3133526 ⤷  Try for Free
China 105392472 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.